Pharmabiz28d
US FDA approves Sanofi-Aventis’ rapid-acting insulin biosimilar product Merilog for improvement of glycaemic control in patients with diabetes
As a rapid-acting insulin, Merilog helps to lower mealtime blood sugar spikes to ... The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA has now approved three biosimilar insulin ...
Benzinga.com27d
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Also Read: Sanofi/Johnson & Johnson ... Merilog helps lower mealtime blood sugar spikes and improve blood sugar control in people with diabetes. The approval is for a 3 milliliter (mL) single ...
Business Insider1mon
FDA approves Sanofi biosimilar product for treatment of diabetes
As a rapid-acting insulin, Merilog helps to lower mealtime blood sugar spikes to improve control of blood sugar in people with diabetes ... of Merilog to Sanofi (SNY)-Aventis U.S. Published ...
Nature14y
Metabolex and Sanofi–Aventis partner on GPCR agonists for type 2 diabetes
Metabolex has entered into an agreement with Sanofi–Aventis for the development of ... is in a Phase II trial for the treatment of type 2 diabetes (T2D). Metabolex will receive upfront and ...
Nasdaq28d
FDA Approves Merilog Rapid-Acting Insulin Biosimilar For Diabetes
(RTTNews) - The U.S. Food and Drug Administration announced that Sanofi-Aventis ... to lower mealtime blood sugar spikes to improve control of blood sugar in people with diabetes.